Carcinoembryonic antigen and CYFRA 21-1 responses as prognostic factors in advanced non-small cell lung cancer
Author(s) -
Akihiro Yoshimura,
Junji Uchino,
Koichi Hasegawa,
Taisuke Tsuji,
Shinsuke Shiotsu,
Tatsuya Yuba,
Chieko Takumi,
Tadaaki Yamada,
Koichi Takayama,
Noriya Hiraoka
Publication year - 2019
Publication title -
translational lung cancer research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.474
H-Index - 41
eISSN - 2226-4477
pISSN - 2218-6751
DOI - 10.21037/tlcr.2019.06.08
Subject(s) - carcinoembryonic antigen , medicine , cytokeratin , lung cancer , univariate analysis , oncology , gastroenterology , multivariate analysis , antigen , tumor marker , cancer , immunohistochemistry , immunology
It is unclear whether changes in serum tumor marker expression post-treatment are of prognostic value. We investigated the associations between changes in serum carcinoembryonic antigen (CEA) and cytokeratin 19 fragment (CYFRA 21-1) after first-line treatment and overall survival (OS) in non-small cell lung cancer (NSCLC).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom